Ergoteles LLC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$10,415
-97.6%
50,314
-52.2%
0.00%
-100.0%
Q3 2021$432,000
-8.1%
105,211
-3.0%
0.02%
+45.5%
Q2 2021$470,000108,5000.01%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 66,951$13,8590.01%
Colorado Capital Management, Inc. 34,165$70.01%
Nantahala Capital Management 160,430$33,2090.00%
Kynam Capital Management, LP 89,886$18,6060.00%
Keebeck Wealth Management, LLC 20,000$4,1400.00%
MORGAN STANLEY 38,404$7,9500.00%
ACADIAN ASSET MANAGEMENT LLC 259,467$520.00%
BlackRock Inc. 169,904$35,1700.00%
Bank of New York Mellon Corp 200,638$41,5320.00%
Citadel Advisors 5,700$1,1800.00%
View complete list of CATALYST BIOSCIENCES INC shareholders